Product Images Lamivudine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Lamivudine NDC 60505-3251 by Apotex Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

LBL150mg60s.jpg - LBL150mg60s

LBL150mg60s.jpg - LBL150mg60s

Each film-coated tablet contains 150 mg lamivudine. It should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and can be tolerated at temperatures between 15°C to 30°C (59°F to 86°F). The drug should be protected from moisture. The usual dosage should be checked from the package insert. The package includes 60 tablets of Lamivudine, USP with National Drug Code 60505-3251-6 by APOTEX CORP. The origin or manufacturing site seems to be Fion, Firica 22226.*

LBL300mg30s.jpg - LBL300mg30s

LBL300mg30s.jpg - LBL300mg30s

Each film-coated tablet contains 300mg lamivudine. They should be stored at a temperature between 20°C and 25°C and can be kept between 15°C and 30°C for a short duration. The medication should be protected from moisture. The usual dosage for the medication can be found in the package insert. The tablets are manufactured by Apotex Corp. The rest of the information is not available.*

chemical-structure - chemical structure

chemical-structure - chemical structure

figure1 - figure1

figure1 - figure1

Lamivudine is a medication available in two dosages of 150mg taken twice a day or 300mg taken once a day. The provided text also includes a graph displaying the treatment time in weeks with corresponding numerical values on the x-axis.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.